Journal profile · HEMATOLOGY
Haematologica
ISSN 0390-6078 · eISSN 1592-8721 · Ferrata Storti Foundation · ITALY
Haematologica: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 8.11; fully open access; APC charged, amount not published; review about 8 weeks (community reports); community-reported acceptance: fairly hard; 543 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Haematologica is published by Ferrata Storti Foundation and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Lymphocytic Leukemia Research, together about 30.4% of its articles. Its main subfields are Hematology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Haematologica publishes articles in the broad field of hematology, reporting on novel important findings in basic, clinical and translational research.
From the journal's Aims & Scope
Research area (LetPub): HEMATOLOGY
Editor-in-chief Jacob M. RowePublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myeloid Leukemia ResearchMedicine12.8%
- Lymphoma Diagnosis and TreatmentMedicine9.3%
- Chronic Lymphocytic Leukemia ResearchMedicine8.4%
- Chronic Myeloid Leukemia TreatmentsMedicine6.5%
- Acute Lymphoblastic Leukemia researchMedicine6.4%
- Multiple Myeloma Research and TreatmentsMedicine5.9%
- Hematopoietic Stem Cell TransplantationMedicine5.8%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Hematology | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Hematology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Hematology | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.11LetPub ·
- Impact factor (publisher) 2025
- 8.2Publisher website ·
- CiteScore 2026-06
- 9.7LetPub ·
- CiteScore (publisher) 2025
- 9.7Publisher website ·
- SJR 2026-06
- 2.53LetPub ·
- SNIP 2026-06
- 1.61LetPub ·
- h-index
- 120LetPub ·
- h-index
- 187OpenAlex ·
- i10-index
- 5,407OpenAlex ·
- 2-year mean citedness
- 1.9OpenAlex ·
- Self-citation rate
- 2.4%LetPub ·
- Share of gold OA articles
- 99.52%LetPub ·
Volume
- Articles per year
- 169LetPub ·
Articles by year OpenAlex count · 9,340 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 787 | 787 | 136 |
| 2025 | 543 | 543 | 867 |
| 2024 | 476 | 476 | 2,420 |
| 2023 | 448 | 448 | 5,203 |
| 2022 | 406 | 406 | 6,533 |
| 2021 | 328 | 328 | 7,491 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 3,000 | No | CC BY, CC BY-NC | |
| OpenAlex | EUR 2,000 | — | — | |
| LetPub | EUR 3,000 | No | — | |
| Publisher website | EUR 2,500 / EUR 3,000 / EUR 3,000 / EUR 3,500 | — | — |
Other charges and waivers (author guidelines)
- Page charges
- EUR 2,500
- Submission fee
- EUR 70
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted12, with length limits
- editorialsEditorials. Editorials that comment on Haematologica articles are by invitation and are published in the same issue as the commented paper.Length not stated
- guideline articlesGuideline articles. These should be produced by an international group of experts.Length not stated
- letters to the editorLetters to the Editor. This type of article is dedicated to the publication of original data that can be reported and discussed in no more than 1,500 text words…Length not stated
- meta-analysisOriginal articles. There is no limit to the number of authors, but this must be commensurate with the complexity of the study. The manuscript should be divided …Length not stated
- original articleOriginal articles. There is no limit to the number of authors, but this must be commensurate with the complexity of the study. The manuscript should be divided …Length not stated
- original articlesOriginal articles. There is no limit to the number of authors, but this must be commensurate with the complexity of the study.Length not stated
- perspective articlesPerspective articles. The format and editorial guidelines for this type of article are the same as for Reviews article.Length not stated
- reviewOriginal articles. There is no limit to the number of authors, but this must be commensurate with the complexity of the study. The manuscript should be divided …Length not stated
- review articleOriginal articles. There is no limit to the number of authors, but this must be commensurate with the complexity of the study. The manuscript should be divided …main text ≤ 5,000 words
- review articlesReview articles. As a rule, Reviews are by invitation.Length not stated
- spotlight review articlesSpotlight Review articles. These brief reviews are by invitation only and are intended to discuss recent advances that have transformed or will transform the he…Length not stated
- systematic reviewOriginal articles. There is no limit to the number of authors, but this must be commensurate with the complexity of the study. The manuscript should be divided …Length not stated
Policy excerpts from the journal's websiteConflicts of interest, License & copyright, Open access, Peer review, Preprints
- Conflicts of interest
Conflict of interest policy Model summary
Haematologica does not consider for publication papers not reporting primary data (such as editorials, review articles, perspective articles, guidelines, position papers and similar articles) that pharmaceutical or medical device company employees and/or medical writers supported by a pharmaceutical or medical device company have had any role in drafting.
Source ↗Publisher website ·- License & copyright 18. COPYRIGHT
Copyright policy Model summary
Authors can choose to publish their manuscripts in Haematologica under a Creative Commons license CC BY-NC or a Creative Commons license CC BY. For other types of copyright management, please contact the Editorial office. According to both CC BY-NC and CC BY licenses, an article may be copied, displayed, distributed, republished or otherwise reused for non-commercial purposes. With the CC BY-NC li…
Source ↗Publisher website ·- Open access
Open access journal; all content immediately free to everyone. Model summary
Open Access Publication and everything published is immediately available for free to everyone.
Source ↗Publisher website ·- Peer review 16. REVIEW PROCESS
All manuscripts submitted to Haematologica are critically revised in accordance with the principles of Peer Review of JCMJE. Each paper is first evaluated by one or more editors, who will assess the overall quality and novelty of the work and the article's appropriateness for the scope of Haematologica. Articles that are not found to be relevant for Haematologica will not be sent out for external …
Source ↗Publisher website ·- Preprints
Preprint policy Model summary
Haematologica does not publish the results of studies that have already been published, even partially, or are going to be published in any form, except for meeting abstracts and manuscripts released as a preprint before or during submission.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Ferrata Storti Foundation
- Country or region
- ITALY
- Language
- English
- ISSN
- 0390-6078
- Electronic ISSN
- 1592-8721
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Haematologica
What CAS zone is Haematologica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Haematologica is in Zone 1 of Medicine, and in Zone 2 of the minor category Hematology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Haematologica?
The latest impact factor listed by LetPub is 8.11; CiteScore 9.7, h-index 187.
How long does peer review take at Haematologica?
Authors report an average review time of about 8 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Haematologica?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 4,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Haematologica?
According to LetPub and DOAJ records, Haematologica is indexed in SCIE, Scopus and DOAJ.
Is Haematologica open access, and what is the APC?
Haematologica is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .